⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ATHE News
Alterity Therapeutics Limited American Depositary Shares
Alterity Therapeutics Releases Appendix 4C – Q1 FY27 Quarterly Cash Flow Report & Corporate Update
globenewswire.com
ATHE
Alterity Therapeutics to Present at the Canaccord Genuity Drug and Device Conference
globenewswire.com
ATHE
Alterity Therapeutics Presents New Analyses of ATH434 Phase 2 Data in Multiple System Atrophy at the 2026 International Congress of Parkinson’s Disease and Movement Disorders
globenewswire.com
ATHE
Alterity Therapeutics to Participate in a Fireside Chat at the Cantor Global Healthcare Conference 2026
globenewswire.com
ATHE
Alterity Therapeutics Announces Granting of New U.S. Composition of Matter Patent for ATH434
globenewswire.com
ATHE
Alterity Therapeutics to Present at the 46th Annual Canaccord Genuity Growth Conference
globenewswire.com
ATHE
Alterity Therapeutics to Present at the 46th Annual Canaccord Genuity Growth Conference
globenewswire.com
ATHE
Alterity Therapeutics Releases Appendix 4C – Q4 FY26 Quarterly Cash Flow Report & Corporate Update
globenewswire.com
ATHE
Alterity Therapeutics to Participate in the Virtual BTIG Biotechnology Conference 2026
globenewswire.com
ATHE
Alterity Therapeutics Receives FDA End-of-Phase 2 Meeting Minutes Confirming Registrational Pathway for ATH434 in Multiple System Atrophy
globenewswire.com
ATHE